Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Bull Exp Biol Med ; 175(2): 219-224, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37464198

ABSTRACT

We studied the influence of recombinant IL-2 and brain-derived neurotrophic factor (BDNF) on the size of the myocardial necrosis zone of rats with systemic inflammatory response syndrome (SIRS). A significant increase in the necrosis zone and the levels of proinflammatory cytokines was revealed in animals with SIRS in comparison with the control. The administration of IL-2 to animals with SIRS significantly reduced the size of the necrosis zone, which was paralleled by a pronounced increase in IL-2 and BDNF in comparison with the corresponding parameters in rats with SIRS that did not receive IL-2. Administration of BDNF to animals with SIRS was followed by normalization of TNFα and IL-1α levels, but did not lead to a decrease in the size of the necrosis zone.


Subject(s)
Myocardial Infarction , Systemic Inflammatory Response Syndrome , Animals , Rats , Interleukin-2/pharmacology , Brain-Derived Neurotrophic Factor/pharmacology , Myocardial Infarction/complications , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , Systemic Inflammatory Response Syndrome/complications , Recombinant Proteins/pharmacology , Body Weight , Feeding Behavior , Male , Rats, Wistar
2.
J Evol Biochem Physiol ; 58(6): 2058-2069, 2022.
Article in English | MEDLINE | ID: mdl-36573161

ABSTRACT

Numerous experimental and clinical studies have shown the effectiveness of various probiotic strains in metabolic disorders, gastrointestinal and liver diseases, immune system pathology. The effects of probiotics on cardiovascular dysfunction are less well known. The development and validation of a new experimental model in rats, including obesity, acute colon inflammation and antibiotic-induced dysbiosis, with common characteristics of systemic inflammatory response syndrome (SIRS), became the basis for investigating the effects of probiotic drugs on myocardial resistance to ischemic-reperfusion injury (IRI) using an in vivo model of infarction after coronary occlusion. A 24% increase in myocardial infarction compared to intact animals (p < 0.05) and significant changes in leukogram, biochemical and immunological parameters were found in Wistar rats with SIRS modelling. Introduction of a mixture of strains of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) to animals with SIRS reduced infarct size to a value close to the control. Rats treated with LA-5 and BB-12 also showed normalization of the leukocyte count, bile acids, transforming growth factor-ß, interleukins: IL-1α, IL-2, IL-6, IL-8, tumor necrosis factor-α, lipopolysaccharide and monocyte chemoattractant protein-1 in blood in comparison with the SIRS group and with the groups treated with other probiotic strains. The obtained data convincingly show the prospects for further study of the cardiotropic potential of probiotic microorganisms in translational studies.

3.
Bull Exp Biol Med ; 170(5): 613-617, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33788104

ABSTRACT

The study focuses on the effects of azithromycin on severity of ischemia/reperfusion myocardial injury during simulated systemic inflammatory response syndrome (SIRS) in primary visceral obesity (PVO). Total ischemia/reperfusion was modeled by Langendorff perfusion of isolated heart with following estimation of the size of myocardial infarction. SIRS was accompanied by an increase in blood levels of proinflammatory cytokines and LPS. Combination of PVO and SIRS produced no significant changes in the infarct size compared to the control. Administration of azithromycin to rats with PVO and SIRS resulted in pronounced alterations of biochemical and immunological parameters, although it did not affect the infarct size. In contrast, the use of tetracycline increased the size of myocardial infarction. This phenomenon should be taken into consideration in antimicrobial therapy.


Subject(s)
Azithromycin/therapeutic use , Myocardial Infarction/drug therapy , Myocardial Reperfusion Injury/drug therapy , Obesity, Abdominal/drug therapy , Obesity/drug therapy , Systemic Inflammatory Response Syndrome/drug therapy , Animals , Cytokines/blood , Lipopolysaccharides/blood , Male , Myocardial Infarction/blood , Obesity/blood , Obesity, Abdominal/blood , Rats , Systemic Inflammatory Response Syndrome/blood
4.
Bull Exp Biol Med ; 168(3): 309-312, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31938911

ABSTRACT

We studied the effect of combined antimicrobial therapy with amoxicillin, metronidazole, and clarithromycin on the severity of ischemia/reperfusion myocardial injury in Wistar rats with alimentary obesity and acute inflammation of the large intestine. General ischemia/reperfusion was reproduced on Langendorff-perfused isolated hearts and infarct size was estimated. Acute inflammation of the large intestine was accompanied by an increase in the blood levels of proinflammatory cytokines. The presence of obesity and acute inflammation of the large intestine did not significantly affect the infarct size in comparison with the control. Administration of antimicrobial drugs to animals with obesity and acute inflammation of the large intestine led to a significant increase in the infarct size, which should be considered when prescribing antimicrobial therapy to patients with comorbidity.


Subject(s)
Inflammation/drug therapy , Inflammation/immunology , Intestine, Large/immunology , Myocardial Reperfusion Injury/drug therapy , Myocardial Reperfusion Injury/immunology , Myocardial Reperfusion Injury/metabolism , Alkaline Phosphatase/metabolism , Animals , Anti-Infective Agents/therapeutic use , Bifidobacterium/drug effects , Body Weight/drug effects , Inflammation/metabolism , Interleukin-8/metabolism , Intestine, Large/microbiology , Lactobacillus/drug effects , Male , Myocardium/metabolism , Obesity/drug therapy , Obesity/immunology , Obesity/metabolism , Random Allocation , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...